|
![]() |
|
|
Catapres: profile and news
Treating ADD With Medication 06 Mar 2006 Monoaminergic Treatment of Schizophrenia Feb 27, 2006 Sleeping Through Detox Poses Hazards Jan 12, 2006 Some fiber supplements cause gas Dec 2, 2005 SUSAN TOMPOR: Picking the right drug plan requires research Nov 16, 2005 Film details Redonto boy's struggle with Tourette's Nov 12, 2005 Behavioral and Pharmacologic Treatment of Aggression in Children ... Oct 3, 2005 URL/Mutual Tracking to Achieve Another Record Year in Sales ... Sep 12, 2005 ADHD: What now? Aug 4, 2005 Russia’s Biggest Spammer Murdered Jul 26, 2005 Par loses ground in 2nd quarter Jul 29, 2005 Tourette Syndrome Jul 19, 2005 German Remedies to market Bio Sidus’ oncology product in India Jun 24, 2005 Psychopharmacology of Autism Spectrum Disorders Jun 20, 2005 Multi-Modal Integrated Treatment for Youth With Bipolar Disorder Jun 20, 2005 German Remedies to market Bio Sidus’ oncology product in India Jun 24, 2005 Psychopharmacology of Autism Spectrum Disorders Jun 20, 2005 Multi-Modal Integrated Treatment for Youth With Bipolar Disorder Jun 20, 2005 Par diversifying into brand-new turf Apr 28, 2005 Par diversifying into brand-new turf 28 Apr 2005 Management of Hypertension in Older Persons Feb 21, 2005 Other information Indication For the treatment of hypertension and maybe used in prophylaxis of migraine or recurrent vascular headache; Menopausal flushing Pharmacology Clonidine is an antihypertensive agent and an epidural agent for refractory cancer pain. Similar to guanabenz in mechanism of action, clonidine is used in the treatment of hypertension, opiate and nicotine withdrawal, vascular headaches, diabetic diarrhea, glaucoma, ulcerative colitis, Gilles de la Tourette's syndrome, menopause symptoms, severe pain in cancer patients refractory to opiate agonists, and neuropathic pain and in the diagnosis of pheochromocytoma. Mechanism Of Action Clonidine acts as an agonist at presynaptic alpha(2)-receptors in the nucleus tractus solitarius of the medulla oblongata. Stimulation of these receptors results in the supression of efferent sympathetic pathways and the subsequent decrease in blood pressure and vascular tone in the heart, kidneys, and peripheral vasculature. Clonidine is also a partial agonist at presynaptic alpha(2)-adrenergic receptors of peripheral nerves in vascular smooth muscle. Drug Category Sympatholytics; Antihypertensive Agents; Analgesics; Central Alpha-Agonists; ATC:C02AC01; ATC:N02CX02; ATC:S01EA03; ATC:S01EA04 Brand Names/Synonyms Adesipress; CCRIS 7787; Catapres; Catapres-Tts; Catapresan; Catapressan; Catarpres; Catarpresan; Chlornidinum; Clonidin; Clonidine; Clonidine Hcl; Clonidinhydrochlorid; Clonidinum [Inn-Latin]; Clonistada; Dixarit; Duraclon; Duraclont; HSDB 3040; Iopidine; Ipotensium; Isoglaucon; M 5041T; M-5041T; ST 155BS; Tenso-Timelets Dosage Forms tablets, patches Absorption 40-60% Interactions -->Interactions for Clonidine: Tablet If a patient receiving clonidine hydrochloride is also taking tricyclic antidepressants, the effect of clonidine may be reduced, thus necessitating an increase in dosage. Clonidine hydrochloride may enhance the CNS-depressive effects of alcohol, barbiturates or other sedatives. Amitriptyline in combination with clonidine enhances the manifestation of corneal lesions in rats Epidural Injection Clonidine may potentiate the CNS-depressive effect of alcohol, barbiturates or other sedating drugs. Narcotic analgesics may potentiate the hypotensive effects of clonidine. Tricyclic antidepressants may antagonize the hypotensive effects of clonidine. The effects of tricyclic antidepressants on clonidine's analgesic actions are not known. Beta blockers may exacerbate the hypertensive response seen with clonidine withdrawl. Also, due to the potential for additive effects such as bradycardia and AV block, caution is warranted in patients receiving clonidine with agents known to affect sinus node function or AV nodal conduction (e.g., digitalis, calcium channel blockers, and beta-blockers.) There is one reported case of a patient with acute delirium associated with the simultaneous use of fluphenazine and oral clonidine. Symptoms resolved when clonidine was withdrawn and recurred when the patient was rechallenged with clonidine. Epidural clonidine may prolong the duration of pharmacologic effects of epidural local anesthetics, including both sensory and motor blockade. Chemical IUPAC Name N-(2,6-dichlorophenyl)-4,5-dihydro-1H-imidazol-2-amine Chemical Formula C9H9Cl2N3 Half Life 12-16 hours Drug Type Approved Drug # Accession No APRD00174 CAS Registry Number 4205-90-7 |
|
Home | About | Cancers | Treatment | Medications Copyright onconews.org 2005. All Rights Reserved. |